Management of Enterocutaneous Fistula

Initial Stabilization

• The American College of Surgeons recommends immediate initiation of aggressive IV fluid resuscitation with normal saline (2-4 L/day) for high-output fistulae (>500 ml/day) to prevent severe dehydration and electrolyte depletion 1, 2
• Monitor and replace ongoing losses continuously, with special attention to sodium replacement, as recommended by the American Society of Colon and Rectal Surgeons 2
• Restrict hypotonic/hypertonic fluids to <1000 ml daily in high-output fistulae, according to the Society of Surgical Oncology 3
• Treat intra-abdominal abscesses with IV antibiotics and radiological drainage as first-line therapy, reserving surgical drainage for failures, as suggested by the European Society of Coloproctology 4, 1, 2
• Initiating anti-TNF therapy before adequate abscess drainage worsens sepsis and increases mortality, as warned by the American Gastroenterological Association 1, 3, 2

Nutritional Support

• The European Society for Clinical Nutrition and Metabolism recommends reserving parenteral nutrition (TPN) for proximal or high-output fistulae where enteral nutrition (EN) is not tolerated 2

Medical Therapy

• The American Gastroenterological Association suggests initiating anti-TNF therapy after sepsis control and abscess drainage for fistulae associated with active Crohn's inflammation 4, 5, 2
• Anti-TNF therapy achieves fistula healing in only one-third of patients, with half of responders experiencing relapse over 3 years, according to the Crohn's & Colitis Foundation 5, 3, 2
• Medical therapy is unlikely to help postoperative fistulae (within 30 days of surgery) and should not delay surgical planning, as stated by the Society of Surgical Oncology 5, 2

Definitive Management

• High-output fistulae (>500 ml/day) require surgery as they cannot be controlled medically, according to the American College of Surgeons 1, 2
• Fistulae associated with bowel stricture and/or abscess require surgical intervention, as recommended by the American Society of Colon and Rectal Surgeons 1, 2
• Delay surgery for 3-12 months after initial diagnosis or previous laparotomy to allow lysis of fibrous adhesions and improve outcomes, as suggested by the European Society of Coloproctology 2

Multidisciplinary Team Approach

• All patients with enterocutaneous fistulae must be managed by a multidisciplinary team given the complexity and association with adverse outcomes including mortality, as emphasized by the American College of Surgeons 5, 1

Critical Pitfalls to Avoid

• Never initiate anti-TNF therapy before adequate abscess drainage—this worsens sepsis and increases mortality, as warned by the American Gastroenterological Association 1, 3, 2
• Never operate immediately without completing the four-step optimization protocol (fluid/electrolyte balance, sepsis control, nutrition, skin care)—this leads to poor outcomes and high mortality, as stated by the Society of Surgical Oncology 1, 2
• Never neglect skin care, as breakdown causes significant additional morbidity and complicates surgical planning, according to the Wound, Ostomy and Continence Nurses Society 1, 3, 2
• Never operate during active Crohn's inflammation without attempting medical control first, as recommended by the Crohn's & Colitis Foundation 2
• Never assume medical therapy will work for postoperative fistulae—plan for surgery early in these cases, as suggested by the European Society of Coloproctology 5, 2

Management of Enterocutaneous Fistulae

Nutritional Support

• The American Society for Parenteral and Enteral Nutrition recommends providing all nutritional support via the enteral route for distal fistulae with low output, and using partial or exclusive parenteral nutrition for proximal fistulae and/or very high output 6, 7
• Early nutritional support, independent of route, decreases the occurrence and severity of fistulae, with up to 70% of patients with fistulae having malnutrition, which is a significant prognostic factor for spontaneous fistula closure 6, 7
• Malnutrition with BMI <20 kg/m² appears as an independent risk factor for complications, and short-peptide-based enteral nutrition for three months achieved successful closure of enterocutaneous fistulae in 62.5% of patients with Crohn's disease 6, 7

Skin and Wound Care

• Negative pressure wound therapy (NPWT) may be used to manage output of an entero-atmospheric fistula and protect skin from fistula output, diverting effluent away from the open abdominal wound and helping achieve secure ostomy bag adhesion 8

Medical Therapy

• Metronidazole 400 mg three times daily and/or ciprofloxacin 500 mg twice daily are appropriate first-line treatments for simple perianal fistulae, and azathioprine 1.5-2.5 mg/kg/day or mercaptopurine 0.75-1.5 mg/kg/day are potentially effective for simple perianal or enterocutaneous fistulae 9

Multidisciplinary Team Approach

• The European Society for Clinical Nutrition and Metabolism recommends that all patients with enterocutaneous fistulae must be managed by a multidisciplinary team, including gastroenterologist, surgeon, and dietitian, given the complexity and association with adverse outcomes including mortality 6, 7

Monitoring for Refeeding Syndrome

• The American Gastroenterological Association recommends implementing standard precautions and interventions to prevent refeeding syndrome, particularly with respect to phosphate and thiamine, in patients with IBD in whom nutritional deprivation has extended over many days 6, 7

Surgical Closure of Enterocutaneous Fistula

Preoperative Optimization Phase

• Drain all intra-abdominal abscesses via interventional radiology before any surgical intervention, as recommended by the European Crohn's and Colitis Organisation, to reduce the risk of sepsis and improve outcomes 10
• Continue nutritional support for a minimum of 5-7 days preoperatively to reduce postoperative morbidity, as suggested by the Journal of Crohn's and Colitis 10
• Consider temporary diverting stoma when high-dose steroids cannot be weaned before emergency surgery, as recommended by the Journal of Crohn's and Colitis, to reduce the risk of complications 10
• Stage procedures when multiple risk factors are present, such as sepsis, malnutrition, and smoking, as recommended by the Journal of Crohn's and Colitis, to improve outcomes 10

Management of Enterocutaneous Fistula

Introduction to Management Principles

• The European Society of Gastrointestinal Endoscopy recommends treating intra-abdominal abscesses with IV antibiotics and radiological drainage as first-line therapy before any other intervention, with the goal of preventing sepsis and promoting healing 11
• The management of enterocutaneous fistulae involves a multidisciplinary team approach, including a gastroenterologist, surgeon, dietitian, and stoma care nurse, to address the complexity and association with adverse outcomes, including mortality 11

Diagnostic Considerations

• The American Gastroenterological Association suggests that MRI is the preferred diagnostic tool for defining fistula anatomy, with the highest sensitivity and specificity, allowing for accurate assessment of fistula tract complexity, associated strictures, and presence of abscesses 11
• Assessing for multiple tracts and associated stenosis is crucial, as these factors reduce healing rates with medical therapy and increase the need for surgery, according to the European Crohn's and Colitis Organisation 11

Medical Therapy

• The American College of Gastroenterology recommends initiating anti-TNF therapy only after sepsis control and abscess drainage, particularly for fistulae associated with active Crohn's inflammation, to minimize the risk of worsening sepsis and increasing mortality 11
• Complex fistulae with multiple tracts have reduced healing rates with anti-TNF therapy, and surgery is often necessary, as stated by the Society of Surgical Oncology 11

Surgical Management

• The Society of American Gastrointestinal and Endoscopic Surgeons suggests that high-output fistulae (>500 ml/day) require surgery for definitive management, and planning should occur after completing the four-step optimization protocol, including fluid and electrolyte balance, sepsis control, nutrition, and skin care 11
• The American Society of Colon and Rectal Surgeons recommends delaying surgery for 3-12 months after initial diagnosis or previous laparotomy to allow lysis of fibrous adhesions and improve outcomes, and never operating immediately without completing optimization 11

Guidelines for Management of Fecocutaneous (Enterocutaneous) Fistulae

Initial Multidisciplinary Management

• Immediate multidisciplinary team care—including aggressive fluid resuscitation, sepsis control, nutritional optimization, and skin protection—is required for all fecocutaneous fistulae; high‑output fistulae (>500 mL/day) ultimately need surgery, whereas low‑output fistulae may close with conservative measures and, when linked to active Crohn’s disease, with anti‑TNF therapy【12】.

Diagnostic Assessment

• Presence of multiple fistulous tracts and associated bowel stenosis predicts failure of medical therapy and a higher likelihood of requiring surgical intervention【12】.

Sepsis Control

• Intra‑abdominal abscesses should be managed first with intravenous antibiotics and image‑guided drainage; operative drainage is reserved for cases that fail percutaneous management【12】.
• Initiating anti‑TNF agents before adequate drainage of abscesses markedly worsens sepsis and increases mortality; in a retrospective series, one‑third of patients on anti‑TNF therapy developed intra‑abdominal abscesses【12】.

Medical Therapy for Crohn’s‑Related Fistulae

• Anti‑TNF therapy may be started only after all abscesses have been fully drained and when the fistula is associated with active Crohn’s inflammation【12】.
• Anti‑TNF agents achieve fistula healing in roughly one‑third of patients, but half of those responders experience relapse within three years【12】.
• Complex fistulae with multiple tracts have lower healing rates with anti‑TNF therapy【12】.
• Medical therapy is generally ineffective for postoperative fistulae occurring within 30 days of surgery; early surgical planning is advised in these cases【12】.

Indications and Timing for Surgery

• High‑output fistulae (>500 mL/day) cannot be controlled medically and therefore require surgical repair【12】.
• Deferring definitive surgery for 3–12 months after initial diagnosis (or after a prior laparotomy) to allow resolution of adhesions improves outcomes; premature resection is associated with poor results【12】.
• Overall, surgery is ultimately required in 41–54 % of patients with fecocutaneous fistulae【12】.

Special Situations

• Enterovaginal and enterovesical fistulae should be managed jointly with medical control of underlying inflammation and definitive surgical resection; conservative treatment alone is insufficient【12】.

Prognostic Outcomes

• Complexity of the fistula—characterized by multiple tracts and associated stenosis—is linked to adverse outcomes, including higher mortality【12】.